Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyrica in Alcohol Use Disorder
NCT03256253Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregabalin in alcohol use disorder (AUD), sponsored by New York State Psychiatric Institute. Started Feb 2018; status: completed.
02
Drugs
pregabalin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03256253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03256253.